| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 63.39B | 64.44B | 61.77B | 61.41B | 69.63B | 52.36B |
| Gross Profit | 23.20B | 25.08B | 16.41B | 13.62B | 14.81B | 15.94B |
| EBITDA | 8.59B | 9.71B | 7.34B | 5.13B | 6.46B | 7.34B |
| Net Income | 2.40B | 3.18B | 1.95B | -1.76B | 420.15M | 953.81M |
Balance Sheet | ||||||
| Total Assets | 64.56B | 71.51B | 65.19B | 63.03B | 64.22B | 64.08B |
| Cash, Cash Equivalents and Short-Term Investments | 6.78B | 8.23B | 8.75B | 7.19B | 6.97B | 6.75B |
| Total Debt | 103.92M | 69.23M | 109.67M | 1.15B | 188.74M | 661.77M |
| Total Liabilities | 11.48B | 14.58B | 13.04B | 13.32B | 13.08B | 13.36B |
| Stockholders Equity | 49.75B | 53.56B | 48.83B | 46.44B | 47.90B | 47.51B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.05B | 3.64B | 35.39M | 694.82M | 3.25B |
| Operating Cash Flow | 0.00 | 9.01B | 7.76B | 4.75B | 5.54B | 7.96B |
| Investing Cash Flow | 0.00 | -10.00B | -4.94B | -5.06B | -4.09B | -4.97B |
| Financing Cash Flow | 0.00 | -401.84M | -1.40B | 299.84M | -1.05B | -1.09B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥97.74B | 7.85 | 7.99% | 3.89% | -2.47% | 15.81% | |
71 Outperform | ¥69.70B | 3.34 | ― | 2.88% | 2.48% | 10.65% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
65 Neutral | ¥21.98B | -17.01 | ― | 2.18% | 4.32% | 62.65% | |
62 Neutral | ¥44.49B | 3.72 | ― | 1.81% | 1.29% | 27.31% | |
61 Neutral | ¥81.75B | 19.64 | 9.07% | 3.61% | 2.90% | 13.95% | |
59 Neutral | ¥473.39B | 15.57 | 6.03% | 1.81% | -0.75% | 33.35% |